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Abstract
We address the problem of counterfactual regression using causal inference (CI) in obser-
vational studies consisting of high dimensional covariates and high cardinality treatments.
Confounding bias, which leads to inaccurate treatment effect estimation, is attributed to
covariates that affect both treatments and outcome. The presence of high-dimensional co-
variates exacerbates the impact of bias as it is harder to isolate and measure the impact of
these confounders. In the presence of high-cardinality treatment variables, CI is rendered
ill-posed due to the increase in the number of counterfactual outcomes to be predicted.
We propose Hi-CI, a deep neural network (DNN) based framework for estimating causal
effects in the presence of large number of covariates, and high-cardinal and continuous
treatment variables. The proposed architecture comprises of a decorrelation network and
an outcome prediction network. In the decorrelation network, we learn a data representa-
tion in lower dimensions as compared to the original covariates, and addresses confounding
bias alongside. Subsequently, in the outcome prediction network, we learn an embedding
of high-cardinality and continuous treatments, jointly with the data representation. We
demonstrate the efficacy of causal effect prediction of the proposed Hi-CI network using
synthetic and real-world NEWS datasets.
Keywords: Causal Inference, Confounding, High-dimensions, Deep neural networks,
Embedding
1. Introduction
In our daily lives, humans often justify several actions and events in terms of cause and
effect and incorporate the feedback into future actions in order to alter future outcomes. On
the other hand, supervised learning based machine learning techniques focus on predicting
outcomes, where outcomes are strongly tied to the nature of training data. However, it is
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possible that when this model is used in real-life scenarios, data generating process may
vary vastly, and hence these models do not generalize well. Hence, there have been several
efforts by researchers to integrate causality into machine learning models for obtaining ro-
bust and generalizable machine learning models. It is well-accepted that obtaining causal
relations from an observational dataset is possible if underlying data generating process is
well-understood. This is often posed as a problem of predicting the effects of interventions
(or treatments) in the data generating process, and such treatments are generally enforced
using policy or operational changes. Furthermore, understanding the effect of interven-
tion requires us accurately answer counterfactual or what-if type questions, which in turn
necessitates modelling the causal relationship between the treatment and outcome variables.
Causal inference (CI) for observational studies lies at the heart of various domains like
healthcare, digital marketing, econometrics based applications, etc, that require quantifying
the effect of a treatment or an intervention on an individual. As an example, consider
a retail outlet optimizing the waiting time at a store since long queues leads to loss in
customer base, in turn leading to low sales. In their historical observational data, consider
the queue-length as a treatment variable and sale as an outcome variable. First, note
that queue-length varies in the training data since it depends on the number of items
purchased by every customer. A discount sale leads to a given customer buying more
leading to higher queue-length. That is, in our training set we observe examples with long
queues and high sales. A naive supervised learning approach might incorrectly predict that
increase in queue-length leads to increase in sales, whereas the true relationship between
queue-length and sales is surely negative on regular days. Typically we have information
regarding discount sales, and including them in the model can correct for such effects. Such
variables affect both, the outcome and the treatment, and hence, these variables are known
as confounding covariates in the CI problem. Similarly, in a digital marketing context, age
can be a confounding covariate which introduces selection bias in providing advertisements
to young, middle-aged and old-aged users and consequently a varying buying behaviour
(outcome). These aspects as well-captured in Simpson’s paradox (Bottou et al., 2013),
which states that the confounding behavior may lead to erroneous conclusions about causal
relations and counterfactual estimation when the confounding variable is not considered in
analysis.
A key problem in modern empirical work is that datasets consists of large numbers
of covariates (Newman, 2012) and high-cardinality treatments (Diemert et al., 2017). We
motivate this using the following real-world scenarios
1. High-dimensional covariates: A typical characteristic of genomic data is the presence
of vast number of covariates. For example, a problem of interest is to genetically
modify the plant Arabidopsis thaliana to shorten the time to flowering (Bu¨hlmann,
2013) since fast growing crops lead to better food production. In the corresponding
dataset, there are 47 instances of the outcome time to flowering and 21, 326 genes
which are construed as covariates. The goal is to causally infer the effects of a single
gene intervention on the outcome, considering the other genes as the covaraites. A
similar (but less severe) situation is also seen in the popular The Cancer Genomic
Atlas (TCGA) project (Weinstein et al., 2013) which is a repository that consists
of gene expression values of 20547 genes of 9659 individuals. Here the goal is to
measure the gene expression values for several treatment strategies like medication,
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Figure 1: a. The t-SNE plot on the left and right depicts the decorrelated transformation
of high-dimensional covariates in data, into a low-dimensional representation,
using the Hi-CI framework. b. Illustrates the dosage embedding to learn a low-
dimensional representation of treatments followed by outcome prediction in the
Hi-CI framework.
chemotherapy and surgery (Schwab et al., 2019), so that the best treatment regimen
is chosen.
2. High-cardinality treatments: We provide the example of the Criteo dataset to motivate
high cardinality treatments. Criteo dataset (Diemert et al., 2017) includes browsing
related activities of users for interaction with 675 campaigns. In the causal setting,
these campaigns are considered as treatments with campaign effect on buying as the
outcome (Dalessandro et al., 2012).
3. High dimensional covariates, high cardinality treatments with dosages: The popular
NEWS datasets consists of news items represented by 2870 bag-of-word covariates.
These news items are read by viewers on media devices. In causal setting, media
devices act as treatments. Since the number of news items can vary from few tens
to hundreds, varying but finite viewing time is considered as dosage levels, while the
readers’ opinion on different media devices is considered as outcome (Schwab et al.,
2019).
In the above applications of healthcare, advertising etc, an individual’s response plays
an important role in guiding practitioners to select the best possible interventions. Hence,
it is essential to build models to handle such high dimensional scenarios. This motivates us
to design machine learning models that abate confounding effects, while being parsimonious
in representation of high-dimensional variables, and adequately flexible.
Related Work: Treatment effect estimation in the presence of high dimensional co-
variates is a well-explored topic in statistical literature on causal inference. In (Robins et al.,
1994), the authors propose techniques based on inverse probability of treatment weighting
(IPTW), which is sensitive to the propensity score model (Fan et al., 2016). Propensity score
estimation is improved by employing covariate balancing propensity scores (CBPS) in high
dimensions (Imai and Ratkovic, 2014; Guo et al., 2016; Fan et al., 2016). LASSO regression
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for high dimensional CI was proposed in (Belloni et al., 2014). Approximate residual bal-
ancing techniques for treatment effect estimation in high dimensions is proposed in (Athey
et al., 2018). A common trait among these works is that they focus on estimating the aver-
age treatment effect (ATE) in the presence of a large number of covariates, but are limited
to settings with only two treatments. In (Schwab et al., 2019), high-cardinality treatments
and continuous treatments are considered. Typically, in the context of continuous treat-
ments, a given treatment is represented using multiple dosage levels (Schwab et al., 2019)
to account for the exploding cardinality of the treatment set (as each dosage is a unique
treatment in itself). In statistical literature, continuous dosages have been handled using
propensity scores (Hirano and Imbens, 2004), doubly robust estimation methods (Kennedy
et al., 2017), generalized CBPS score (Fong et al., 2018), using estimation frameworks for
both treatment assignment and outcome prediction (Galagate, 2016).
Modern deep neural networks (DNN) based methods employ matching or balancing
techniques for compensating confounding bias. Existing DNN based architectures for the
multiple treatment scenario as proposed in (Sharma et al., 2020; Schwab et al., 2018) have
a severe limitation with respect to their architectures. They employ a separate regression
network per treatment, and hence, these neural networks cannot be used in the presence of
a large number of treatments. Furthermore, in the presence of high-dimensional covariates,
it is essential to design a parsimonious, yet lossless representation of these covariates. In
several works such as (Johansson et al., 2016; Shalit et al., 2017), a latent representation
for covariates is learned by minimizing the discrepancy distances of the control and treat-
ment populations to compensate for confounding bias, in the presence of binary treatments.
Since such a data representation is not lossless, this approach is not suitable in the pres-
ence of high-cardinality variables. An autoencoder is used to learn an unbiased lossless
representation of covariates, uncorrelated with respect to the multiple, yet small number of
treatment variables (Atan et al., 2018; Zhang et al., 2019). On the other hand, matching
based DNN techniques find similar individuals with dissimilar treatments using propensity
scores (Schwab et al., 2018; Sharma et al., 2020; Ho et al., 2007). Matching is often accom-
plished using nearest neighbour match (Ho et al., 2007), propensity score (Schwab et al.,
2018) or generalized propensity score (Sharma et al., 2020). These techniques are compu-
tationally infeasible in the presence of high-cardinality treatment variables as good recipes
for matching require spanning the entire dataset in search of alternate treatment variables
while ensuring a balance in the number of individuals per treatment. However, the success
of the DNN based causal CI techniques and vacuum in the literature on architectures that
handle large number of covariates and treatments in observational datasets motivates us to
address this problem.
Contributions: In the presence of high-cardinality treatment variables, the number of
counterfactual outcomes to be estimated is much larger than the number of factual obser-
vations, rendering the problem to be ill-posed. Furthermore, lack of information regarding
the confounders among large number of covariates pose challenges in handling confounding
bias. Hence, it becomes essential to find a lower dimensional manifold where an equivalent
problem of causal inference can be posed, and counterfactual outcomes can be computed.
To this end, we propose a DNN based Hi-CI, specifically designed to measure causal effects
in the presence of countably large number of covariates and high-cardinality treatments.
We propose a novel loss function which is designed to achieve the following goals:
4
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• Obtain an autoencoder based data representation for high-dimensional covariates
while simultaneously handling confounding bias using a decorrelation loss, as depicted
in (a) of Fig. 1.
• Caters to both, a large number of discrete, and continuous treatments, where a con-
tinuous treatment is characterised by a fixed number of dosage levels.
• Obtain a per-dosage level embedding layer to learn the low-dimensional representation
of the high-cardinality treatments by jointly training the network using root mean
square (RMSE) loss and a sparsifying mixed norm loss function as depicted in lower
part (b) of Fig. 1.
We demonstrate that the proposed Hi-CI architecture outperforms the state-of-the-art
CI techniques such as perfect match (PM) (Schwab et al., 2018), MultiMBNN (Sharma et al.,
2020), Deep-Treat (Atan et al., 2018) and DRNet (Schwab et al., 2019) in the presence of
high-dimensional variables. We use precision in estimation of heterogeneous effect (PEHE)
and mean absolute percentage error (MAPE) over the ATE as metrics in all the experi-
ments. For treatments with dosages, we use mean integrated square error (MISE) as a
metric, and in addition, we also introduce a new metric for computing MAPE over the
dosage effect.
2. CI in High dimensions: Preliminaries and Loss Function
In this section, we describe the causal inference problem, especially in the presence of
a large number of covariates and treatments. We motivate the need for finding a low-
dimensional representation of the high-cardinality covariates and treatments and describe
the loss function that helps to learn these representations from data and hence provide the
basis for understanding the Hi-CI DNN described in the sequel.
2.1 Causal Inference Preliminaries
We consider training data DCI , comprising of N samples from an observational dataset,
where each sample is given by {xn, tn,yn}, where xn ∈ X. Each individual (also called
context) n is represented using P covariates, i.e., xn,p denotes the p-th covariate of the n-th
individual, for 1 ≤ n ≤ N . Furthermore, an individual is subject to one of the K treatments
given by tn = [tn(1), . . . , tn(K)], where each entry of tn is binary, i.e., tn(k) ∈ {0, 1}. Here,
tn(k) = 1 implies that the k-th treatment is provided. We assume that only one treatment
is provided to an individual at any given point in time, and hence, tn is an one-hot vector. A
counterfactual is defined based on K−1 alternate treatments, and corresponding outcomes
are referred to as counterfactual outcomes. Accordingly, the response vector for the n-th
individual is given by yn ∈ RK×1, i.e., the outcome is a continuous random vector with K
entries denoted by yn(k), the response of the n-th individual to the k-th treatment. The
set of counterfactual responses for the n-th individual comprises of response to treatments
l 6= k, given by yn,l, and the size of this set is K−1. In the case of continuous treatment, we
assume that tn(k) ∈ R which implies that tn ∈ RK×1, that is the treatment is a real-valued
vector. However, for ease of representation, we cast the continuous treatment variable using
a finite set of E dosage levels where E remains constant across treatments. Following the
5
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notation for discrete treatments, the outcome is a continuous random vector denoted by
yn(ke), where 1 ≤ ke ≤ KE, is the response of the n-th individual to the e-th dosage level of
the k-th treatment. In the case of discrete treatment, the maximum size of outcomes to be
predicted by the DNN is N(K − 1), while the number of available factual outcomes are N
in number. It is evident that this problem is ill-posed when K is large. Furthermore, in the
case of continuous treatments, we effectively have KE treatments, leading to N(KE − 1)
counterfactual responses.
In this work, we consider observational studies where there are large number of covariates
P and large number of treatments K. Our goal is to train a DNN model to overcome
confounding and perform counterfactual regression, i.e., to predict the response given any
context and treatment, for large P and K. In the sequel, we describe different components
of the the loss function that tackles confounding bias, high-dimensional treatments and
high-dimensional covariates.
2.2 Learning Representations from Data
The crux of the loss function in CI for observational studies lie in techniques employed to
compensate for the confounding bias. In this direction, we employ autoencoders which si-
multaneously encourage confounding bias compensation and learning compressed represen-
tation for the high-dimensional covariates. Alongside, we employ RMSE with mixed-norm
regularizer based loss-function to obtain a low-dimensional representation for treatments.
In the sequel, we describe the mathematical constructs of learning the representation and
the loss function.
2.2.1 Data Representation using autoencoders
In this work, we propose to use the autoencoder to jointly obtain a low-dimensional repre-
sentation of the high-dimensional covariates and alleviate the effect of confounding. Let T
represent the set of treatments, and Tk ∈ T be a random variable; instantiation for the n-th
individual is tn(k). Using an autoencoder, we seek a mapping from the space of covariates
X ∈ RN×P , such that Φ : X → R, where R ∈ RN×L is the representation space. The
mapping Φ is such that,
• The induced distribution of the treatments over R, which we denote p(Tk|Φ(X)) is
free of confounding bias for all k.
• The representation of xn under Φ(·) for all n is lossless.
• It maps higher dimensional covariates in P to a low-dimensional space of size L, i.e.,
L < P .
A typical propensity score based matching approach addresses the issue of confounding
bias by balancing the propensity score to obtain similar covariate distributions across treated
populations. Mathematically, a sub-sample Xs of the original sample is considered such that
it ensures that the following condition holds:
p(T1|Xs) = p(T2|Xs) = . . . = p(TK |Xs). (1)
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Note that the condition stated above does not necessitate that treatment and covariates
variables are uncorrelated. On the other hand, the loss function associated to the autoen-
coder imposes a far more stringent condition (Atan et al., 2018) such that
p(Tk|X) = p(Tk), ∀k, (2)
for the entire sample DCI . Autoencoders have been employed in the literature for address-
ing some of the tasks such as lossless data representation (Atan et al., 2018; Ramachandra,
2018). However, to the best of the authors’ knowledge, this is the first-of-its-kind approach
where an autoencoder is used to jointly accomplish the goals as specified above, and pri-
marily, low-dimensional representations.
To ensure lossless data representation, the loss function associated with the autoencoder
jointly minimizes the mean-squared error loss between the reconstructed and the original
covariates, and the distance between the unbiased (p(Tk)) and the biased treatment distribu-
tions (p(Tk|Φ(X))) for all k, while maintaining the resultant mapping in a lower dimension
as compared to the original covariates (L < P ). These goals can be achieved by using the
following loss function:
L1(Φ,Ψ, β) = Lce(Φ(X)) + βLae(Φ(X),Ψ(Φ(X))), (3)
where Lce(Φ) is the cross-entropy measure. The cross-entropy loss is directly proportional
to the Kullback-Liebler divergence between the distributions in question, and hence it is
an appropriate metric to minimize the divergence between p(Tk) and p(Tk|Φ(X)) for all k.
Accordingly, Lce(Φ) is given by
Lce(Φ) = −
∑
T∈T
p(T ) log(p(T |Φ(X))). (4)
Furthermore, the loss term Lae(Φ,Ψ) is employed to minimize the mean-squared loss be-
tween the reconstructed and the original covariates in the autoencoder. Mathematically,
Lae(Φ,Ψ) = 1
PN
N∑
n=1
P∑
p=1
||(xn,p − (Φ ◦Ψ)(xn,p))||2, (5)
where Ψ is the decoder mapping such that Ψ : R → X and ◦ is a composition operator,
and L < P , which ensures that we obtain a low-dimensional, yet meaningful representation
of the high-dimensional covariates.
As a regularizer, we propose to employ the mixed norm on the difference of means, repre-
sented using the matrix MD. The columns of MD are given by µD,(Ti,Tj) =
1
LK(K−1)(µTi(Φ(X))−
µTj (Φ(X))), where µTi(Φ(X)) ∈ RL×1 is the mean of representation for all individuals in X,
given by Φ(X), that undergo treatment Ti. Since all possible pairs of treatments (Ti, Tj), for
all Ti and Tj are considered, MD is of dimension RL×(K(K−1)). The mixed norm regularizer
on MD, denoted as L2,1(MD), is as follows:
L2,1(MD) =
K(K−1)∑
u=0
√√√√L−1∑
v=0
|MD(u, v)|2. (6)
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Combining the above mentioned loss functions, we obtain the following loss function from
the decorrelating network:
LD(Φ,Ψ, β, γ) = Lce(Φ) + βLae(Φ,Ψ) + γL2,1(MD). (7)
The above objective function cannot be computed directly since both p(Tk|Φ(X)) and p(Tk)
are unknown for any k. The estimates of p(Tk) for 1 < k ≤ K is given by (Atan et al.,
2018):
p(Tk = t) =
∑N
n=1 I(tn(k) = t)
N
, (8)
where I(·) is the indicator function. Essentially, p(Tk) provides a count-based probability
of k-th treatment. Further, the functional form of p(Tk|Φ(xn)) is assumed to be similar to
logistic regression:
p(Tk|Φ(xn)) =
exp((θTk)
TΦ(xn))∑K
k=1 exp((θTk)
TΦ(xn))
, (9)
where θTk ∈ RL×1 are the per-treatment parameters of the logistic regression framework.
This results in
Lce(Φ) = −
K∑
k=1
p(Tk)(θTk)
TΦ(xn)− log
(
K∑
k=1
(θTk)
TΦ(xn)
)
. (10)
2.2.2 Embeddings for high-dimensional treatment
As mentioned in the previous subsection, the goal of this work is to design DNN based CI
model for datasets with large number of unique treatments. While a single bit is sufficient
to represent binary treatments (Johansson et al., 2016), a one hot representation is used
within the DNN to represent a categorical treatment for a given user (Sharma et al., 2020).
In the presence of high-cardinality treatment variables, i.e., treatments with several unique
categories, the size of the one-hot vector becomes unmanageable. Furthermore, DNN ar-
chitectures that cater to multiple treatments often use a sub-divided network as in (Schwab
et al., 2018) and (Schwab et al., 2019), with one branch per treatment. Such a branching
network based DNN architecture becomes computationally intractable as the number of
treatments increase.
An aspect that matters the most about one-hot encoding is the fact that one-hot map-
ping does not capture any similarity in treatment categories. For instance, if treatments
t1 and t2 are drugs for lung-related issues, and t3 is a treatment for skin-acne which is
seemingly an unrelated issue, t1, t2 and t3 are equidistant in the one-hot encoding space.
We propose to learn a representation of treatments denoted as Ω : [Φ(X),T] → Y, where
Y represents the space of output response vectors of length K, and the embedding Ω en-
capsulates closeness property of treatments. Such representations of the treatment space is
extremely relevant in the current day observational studies, as explained in the introduction.
The impact of the embedding is realised in the outcome prediction part of the network.
The loss on the outputs of the outcome prediction layer is the root mean square error
8
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(RMSE) loss given by
LRMSE(y, yˆ) =
√√√√ 1
N
N∑
n=1
K∑
k=1
||yn(k)− yˆn(k)||2 (11)
where yˆn = Ω([Φ(xn), tn]
T ).
Although the impact of embedding is evident only in the above loss function, note that
the training of the Hi-CI framework incorporates all of the loss functions combined in (7)
and (11). Intuitively, through the mixed norm based regularizer in (6), we minimize the
distance between multiple populations whose covariate information is summarized by Φ(X)
and hence, we are able to exploit the similarity properties in the treatment itself. When
we train the network using (11) along with (6), in addition to promoting parsimonious
representations owing to similarity of treatments, we also ensure that such representation
leads to a response close, in the sense of RMSE, to the true label.
2.3 Modified Loss Function when E > 1
In the case of continuous treatment, we represent a treatment as consisting of multiple
dosages (Schwab et al., 2019). In particular, we assume that each treatment is specified
by a set of E dosage levels, i.e., E remains constant across treatments. In the design of
DNN, we assume that the treatment is affected by the confounding bias, but the dosage
administered is not. However, since we need to infer the per-dosage level counterfactual, we
exploit the dosage information available in the labels yn(ke) outcome prediction network.
Accordingly, we incorporate the dosage levels in a generalised RMSE loss function:
LRMSE(y, yˆ) =
√√√√ 1
N
N∑
n=1
K∑
k=1
E∑
e=1
||yn(ke)− yˆn(ke)||2, (12)
where yˆn = Ωe([Φ(xn), tn]
T ). Note that if we set E = 1 in (12), we obtain (11). Hence,
we essentially aggregate the characteristics of all observed individuals subjected to any
treatment, and having been administered a given dosage en.
In order to implement the loss function associated with continuous treatments, it is
also essential to make changes in the network architecture. In the sequel, we describe the
proposed DNN architecture of Hi-CI in tandem with components of the loss-function as
described in (11) and (7). We also discuss the changes in the network architecture due to
the generalised RMSE loss in (12).
3. Hi-CI: Proposed Deep Neural Network Architecture
In this section, we describe the novel Hi-CI network architecture proposed for CI in high-
dimensions. The network consists of two components, a decorrelation network and a re-
gression (or outcome prediction) network. The decorrelation network consists of the au-
toencoder and the corresponding loss function is given in (7). The loss function pertaining
to the regression network is given by (11). The overall loss function corresponding to the
9
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X
Φ(X)
tnp(Tk)
en
X
′
Ω1
ΩE
Ω2
1 ≤ n ≤ N
1 ≤ n ≤ N
Encoder
Φ
Decoder
Ψ
1 ≤ k ≤ K
Figure 2: Hi-CI: Proposed DNN architecture for inference in the presence of high-
cardinality covariates and continuous treatments. The blocks in cyan represent
the parameters to be tuned, and the blocks in grey denote the loss functions.
decorrelation network and regression network is given by
L(Φ,Ψ,Ω, β, γ, λ) = LD(Φ,Ψ, β, γ) + λLRMSE(y, yˆ) (13)
As explained in the previous section, in the case of continuous treatments, we modify
the structure of the regression network alone. In the regression network, we obtain the
per-dosage level embedding, which we denote as Ωe(·), where 1 ≤ e ≤ E. We use the
concatenation of learned representation Φ(xn), treatment vector tn as an input to the
embedding layer. The dosage information is used to obtain a subdivided network, i.e., in
this work we split the network based on dosages and not treatments since E  K. The
overall loss function for continuous treatments is given by
L(Φ,Ψ,Ωe, β, γ, λ) = LD(Φ,Ψ, β, γ) + λLRMSE(y, yˆ) (14)
The generalized architecture of the Hi-CI network with continuous treatments is as depicted
in Fig. 2 (details in Supplementary Information). For discrete treatments, E = 1, and
hence one embedding sub-network (Ω(·)) is used instead of multiple sub-networks (Ωe(·))
for outcome prediction.
4. Experimental Set-up
In this section, we describe the experimental setup to demonstrate the efficacy in coun-
terfactual regression of the Hi-CI algorithm and report the results obtained. We report
the results on a synthetically generated dataset (Sun et al., 2015), and the semi-synthetic
NEWS dataset (Johansson et al., 2016) for evaluation. 1 Since a counterfactual outcome is
not available, it becomes impossible to test CI algorithms in the context of counterfactual
prediction. As a solution, data generating processes (DGP) are employed for demonstrating
1. The simulated datasets will be available upon request from authors post publication of the paper.
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the results. In this section, we describe the datasets employed as well as the corresponding
DGPs employed for each dataset. Furthermore, we describe the metrics we use for evalu-
ating the Hi-CI framework where E = 1, namely precision in estimation of heterogeneous
effect (PEHE) (Shalit et al., 2017) and Mean Absolute Percentage Error (MAPE) over Av-
erage Treatment Effect (ATE) (Sharma et al., 2019). In the case of continuous treatments,
i.e., for E > 1, we evaluate the Hi-CI framework using Mean Integrated Squared Error
(MISE) and MAPE over ATE with dosage metric.
4.1 Datasets
In this subsection, we describe the datasets and the DGP employed for each dataset.
• Synthetic (Syn): We use a synthetic process described in (Sun et al., 2015) to generate
data for both multiple treatment as well as continuous valued treatment scenario. The
DGP gives us the flexibility to simulate the counterfactual responses along with the
factual treatments and responses, thereby helping in better evaluation of the proposed
model. The generation process in (Sun et al., 2015) allows for 5 confounding covariates
while the remaining P−5 covariates are non-confounding. The number of covariates P ,
data size N and cardinality of treatment set K are fixed according to the requirement
of experiment and is described in detail in section 5.
• NEWS: We consider the publicly available bag-of-words context covariates for NEWS
dataset 2. The DGP as given in (Schwab et al., 2018) is employed for synthesizing
one of multiple treatments and corresponding response for each document (context) in
NEWS dataset. This generation process is extended to treatments with dosage levels
by (Schwab et al., 2019) and is used for experimental evaluation of continuous valued
treatments. The number of covariates P is fixed to 2870 and value for N,K is given
in sec. 5 based on experimental requirements.
We use the convention of naming each newly synthesized dataset as a conjunction of the
original dataset name and the treatment set cardinality (K) for all experiments in section 5.
For example, ’NEWS4’ denotes NEWS dataset for K = 4 treatment case.
4.2 Metrics
In this subsection, we describe the performance metrics used for evaluating the proposed
approach.
4.2.1 Precision in Estimation of Heterogeneous Effect (PEHE)
We use the definition of PEHE as specified in (Schwab et al., 2018) for multiple treatments
as:
ˆP =
1(
K
2
) K∑
m=1
m−1∑
r=1
ˆPm,r (15)
ˆPm,r =
1
N
N∑
n=1
([yn(m)− yn(r)]− [yˆn(m)− yˆn(r)])2 (16)
2. https://github.com/d909b/perfect match
11
Sharma, Gupta, Prasad, Chatterjee, Vig and Shroff.
where yn(m),yn(r) are the response of the n-th individual to treatments Tm and Tr respec-
tively.
4.2.2 Mean Absolute Percentage Error (MAPE) over Average Treatment
Effect (ATE)
We use MAPEATE as a metric to estimate error in predicting average treatment effect for
high-cardinality treatments, and is given by:
MAPEATE =
∣∣∣∣ATEactual −ATEpredATEactual
∣∣∣∣ , (17)
where,
ATEactual =
1
N
N∑
n=1
yn(k)− 1
K − 1
K∑
l=1,l 6=k
yn(l)
 , (18)
and ATEpred is obtained by replacing yn(k) in the above equation by its predicted value
yˆn(k) for all k.
4.2.3 Mean Integrated Squared Error (MISE)
For high cardinality treatments with dosages, we use MISE as a metric (as in (Schwab
et al., 2019)). This is the squared error of dosage-response computed across the dosage
levels and averaged over all treatments and entire population.
4.2.4 MAPE over ATE with dosage
We introduce a novel metric MAPEDosATE for high cardinality treatments with dosages. This
metric is useful for evaluating effect of a dosage level for factual treatment as opposed to
counterfactual treatments. It is given by:
MAPEDosATE =
∣∣∣∣∣ATEDosactual −ATEDospredATEDosactual
∣∣∣∣∣ , (19)
where,
ATEDosactual =
1
E
E∑
e=1
 1
NE
NE∑
n=1
yn(ke)− 1
K − 1
K∑
l=1,l 6=k
yn(le)
 , (20)
and and ATEDospred is obtained by replacing yn(ke) in the above equation by its predicted
value yˆn(ke) for all k.
4.3 Baselines
We use the following DNN based approaches to baseline Hi-CI for high cardinality treat-
ments:
• O-NN: O-NN does not account for confounding bias, we thereby bypass the decorrela-
tion network of Hi-CI and X is directly passed to the outcome network.
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• MultiMBNN: Matching and balancing based architecture proposed in (Sharma et al.,
2020)
• PM : Propensity based matching (Schwab et al., 2018) employed for counterfactual
regression.
• Deep-Treat+: Deep-Treat (Atan et al., 2018) learns bias removing network and policy
optimization network independently to learn optimal, personalized treatments from
observation data. In order to use Deep-treat as a baseline, we modify Deep-Treat to
Deep-Treat+ and jointly train decorrelation network obtained from Deep-Treat, and
outcome network of Hi-CI to baseline our approach.
• DRNet: is a DNN based technique (Schwab et al., 2019) to infer counterfactual re-
sponses when treatments have dosage values. We use this to baseline Hi-CI continuous
valued treatment case.
5. Experimental Results
We perform extensive experimentation using the proposed Hi-CI framework on Syn and
NEWS datasets. Our experimental evaluation is primarily aimed at evaluating the perfor-
mance of Hi-CI under three broad settings: high-cardinality treatments; continuous valued
treatments and high number of covariates.
5.1 High-cardinality treatments (E = 1)
5.1.1 Effect of increasing the cardinality of treatment set
Here, we evaluate Hi-CI in scenarios where the cardinality of treatments increases, while
E = 1 . With increase in K, sample size N is also proportionally increased to keep the
average number of samples per treatment (given by NK ) constant. In Table 1, we report the
mean and standard deviation of the performance metrics PEHE,MAPEATE for Syn and
NEWS datasets. For both the datasets, performance errors increase with increase in K. In
the case of Syn dataset, error in estimating ATE is much lower than NEWS dataset for very
large number of treatments. We can explain this by noting that the number of covariates
(perhaps confounding too) in NEWS dataset are of the order of 2000 whereas in Syn, the
number of covariates are fixed to 10 with 5 confounding variables.
5.1.2 Varying number of treatments K for fixed N
We illustrate the performance of the Hi-CI framework keeping a sample size of N = 10000
while we vary the cardinality of treatment set from K = 10 to 100, which implies that
we see a decrease in the ratio NK . From Table 2, we observe that for Syn dataset, as
the average number of samples per treatment decreases, PEHE and MAPEATE increase.
However, for the NEWS dataset, no such trend is observed due to a large number but sparse
covariates. Furthermore, in Fig. 3 we depict the counterfactual RMSE for Syn datasets
under this experimental setting. We observe a slight increase in the counterfactual error as
K increases, demonstrating that although the problem is harder, Hi-CI network prediction
performs reasonably well.
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Table 1: Effect of increasing K with fixed NK ratio (
N
K = 285.7) on high cardinality treat-
ments with E = 1. Mean and standard deviation of the metrics for multiple runs
with varying seed points is reported.
Dataset
√
ˆP MAPEATE
Syn35 3.6764, 0.4037 0.074, 0.0188
Syn48 7.4350, 0.1705 0.1494, 0.0048
Syn103 7.0612, 0.5124 0.1681, 0.0054
Syn216 7.7069, 0.1531 0.1943, 0.0101
NEWS35 7.6256, 0.0243 0.393, 0.0095
NEWS48 8.2675, 0.0522 0.4821, 0.0105
NEWS100 8.9334, 0.6425 0.566, 0.0245
NEWS200 9.4679, 0.8524 0.8924, 0.0859
Table 2: Mean and standard deviation of
√
ˆP , MAPEATE for NEWS , Syn datasets with
varying NK ratios. Results are computed for multiple runs of each dataset simulated
for varying seed points.
Dataset NK
√
ˆP MAPEATE
Syn10 1000 1.6188,0.0262 0.046,0.008
Syn35 285.7 3.6764,0.4037 0.074,0.0188
Syn55 181.8 7.1836,0.8065 0.1378,0.0148
Syn100 100 9.1706,0.8755 0.1812,0.0129
NEWS10 1000 7.8563,0.0214 0.6223,0.115
NEWS35 285.7 7.6256,0.0243 0.393,0.0095
NEWS55 181.8 7.7383,0.0273 0.4515,0.0360
NEWS100 100 8.1432,0.0476 0.507,0.0171
Figure 3: Counterfactual RMSE for increasing K, constant N = 10000 on SynK datasets.
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Table 3: Effect of decorrelation loss function LD(·) as compared to Lce(·) + Lae(·) and
L2,1(·) + Lae(·) for E = 1 case.
√
ˆP MAPEATE
Dataset NK P L1(·) L2,1(·) + Lae(·) LD(·) L1(·) L2,1(·) + Lae(·) LD(·)
Syn10 1000 10 1.6390, 0.1125 1.6161, 0.0506 1.6188, 0.0262 0.0645, 0.0243 0.0573, 0.0111 0.046, 0.008
Syn35 285.7 10 5.3784, 0.4538 4.2283, 0.8902 3.6764, 0.4037 0.1686, 0.0181 0.0990, 0.0407 0.074, 0.0188
Syn55 181.8 10 7.5039, 0.4699 7.5173, 0.5540 7.1836, 0.8065 0.1443, 0.0115 0.1472, 0.0103 0.1378, 0.0148
Syn100 100 10 9.7575, 0.7000 11.3353, 0.7624 9.1706, 0.8755 0.2214, 0.0394 0.2138, 0.0067 0.1812, 0.0129
NEWS10 1000 2870 7.8601, 0.0487 7.8541, 0.0285 7.8563, 0.0214 0.6288, 0.0146 0.6325, 0.0027 0.6223, 0.115
NEWS35 285.7 2870 8.3121, 0.0442 8.3425, 0.0600 7.6256, 0.0243 0.4875, 0.0141 0.4874, 0.0081 0.393, 0.0095
NEWS55 181.8 2870 7.8019, 0.0297 7.8212, 0.1648 7.7383, 0.0273 0.4792, 0.0173 0.6454, 0.0945 0.4515, 0.0360
NEWS100 100 2870 8.3275, 0.0792 8.2897, 0.0284 8.1432, 0.0476 0.5028, 0.0169 0.4844, 0.0050 0.507, 0.0171
5.1.3 Loss Functions Analysis
We conducted extensive experimentation to validate the impact of the proposed decorrela-
tion loss function LD(·) given in (7), in learning the low-dimensional representation of data
as the cardinality of treatments increases. We set the sample size to be constant while K
increases, and consequently the ratio NK decreases. From Table 3, we see that PEHE and
MAPEATE) decrease significantly when the lower-dimensional representation is learned
using LD(·) loss function (7), a combination of losses that caters to reduction in bias via
Lce(·), reduction in information loss via Lae(·), and similarity-exploiting via L2,1(·) as com-
pared to case where only L1(·) or Lae(·) + L2,1(·) is used. Note that L1(·) is considered as
decorrelation loss in Deep-Treat+.
5.2 Varying number of covariates P
We illustrate the performance of the Hi-CI framework by increasing the number of covari-
ates, retaining the sample size fixed at N = 10000, i.e., PN varies from 0.001 to 0.1. In the
context of Syn35 dataset, we see from Table 4 that as the number of covariates increase,√
ˆP is as low as 3.67 and MAPEATE is lower than 0.17, thereby showing the strength of
the proposed network in handling high dimensional covariates.
Table 4: Effect of increasing PN for Syn35 dataset on PEHE (
√
ˆP ) and error in ATE
measured using MAPEATE .
P
N
√
ˆP MAPEATE
0.001 3.6764, 0.4037 0.074, 0.0188
0.005 5.1845, 0.7025 0.1388, 0.0192
0.01 6.2392, 0.3310 0.1557, 0.0132
0.05 6.0466, 0.4325 0.1720, 0.0104
0.1 6.2516, 0.6775 0.1757, 0.0260
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5.3 High-cardinality treatments with continuous dosages (E > 1)
In Table 5, we illustrate the effect of varying number of dosage levels on the performance
metrics for treatments with dosage. Note that the error decreases as the number of dosage
levels E increase. We measure the dose-reponse error using MISE and average dosage
effect given by MAPEDosATE in Table 5 show that varying dosage levels does not impact
the performance much. Note that this is partly since context covariates are confounders
for treatments, but not for dosage levels in the NEWS dataset. Furthermore, In case of
synthetic dataset, although covariates are confounders for both treatments and dosages, we
see that low-complexity networks are sufficient to capture the dosage-response. As pointed
in Sec. 2.1 that our network is designed under the assumption treatment is confounded but
not dosage values. However the results for Syn dataset, as seen in Table 5, show that Hi-CI
can handle covariates confounding dosages as well.
Table 5: Varying dosage levels E for N = 10, 000 on treatments with dosage. Mean and
standard deviation of
√
MISE, MAPEDosATE computed on test set of datasets
generated by varying seeds.
Dataset E
√
MISE MAPEDosATE
Syn25 3 2.126, 0.0146 0.1193, 0.0024
Syn25 6 1.980, 0.0157 0.1066, 0.0038
Syn25 8 2.146, 0.014 0.124, 0.0021
Syn25 10 3.148, 0.052 0.162, 0.0046
NEWS25 3 11.2346, 0.1221 0.2462, 0.0584
NEWS25 6 11.4860, 0.1568 0.3254, 0.1221
NEWS25 8 11.0114, 0.0856 0.1457, 0.0462
NEWS25 10 11.9086, 0.2795 0.6890, 0.1258
5.4 Comparative analysis with baselines
In this section, we illustrate the performance of the Hi-CI network as compared to the
popular baselines in literature.
5.4.1 High dimension treatments and covariates for E = 1
In Table 6, we depict the performance of Hi-CI framework as compared to baselines (refer
Section 4.3) with varying number of treatments for low and high dimensional covariates. In
order to evaluate the performance in high dimensions, NEWS100 with PN = 0.287 is shown
to do exceedingly well in terms of both
√
ˆP and MAPEATE , as compared to previous
works. It is seen that for lower-cardinality treatment set (Syn4, NEWS4) our approach
beats state of art marginally. This is expected behavior since baselines such as (Sharma
et al., 2020) and (Schwab et al., 2018) are optimized for such scenarios. However as the
number of treatments increase, our approach outperforms baselines by huge margins. This
behaviour is observed for both high and low number of covariates.
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Table 6: Performance of Hi-CI as compared to state-of-the-art approaches: PM, MultiMBNN
for high cardinality treatments.
√
ˆP MAPEATE
Dataset PN
N
K PM MultiMBNN Hi-CI PM MultiMBNN Hi-CI
Syn4 0.001 2500 1.9004, 0.1124 1.8272, 0.0928 1.3520, 0.0542 0.4249, 0.1142 0.3917, 0.1075 0.0150, 0.0022
Syn10 0.001 1000 0.4249, 0.1142 0.3917, 0.1075 0.0150, 0.0022 5.8976, 0.1175 5.7752, 0.1100 1.6188, 0.0262
Syn35 0.001 285.7 18.5894, 0.2329 17.6520, 0.2032 3.6764, 0.4037 0.4726, 0.0562 0.4528, 0.0864 0.074, 0.0188
Syn100 0.001 100 32.0424, 0.9862 32.304, 0.9652 9.1706, 0.8755 1.1225, 0.1585 1.2854, 0.2012 0.1812, 0.0129
NEWS4 0.287 2500 8.1842, 0.4202 7.6606, 0.4077 6.4120, 0.3016 0.3232, 0.0574 0.1622, 0.0381 0.0984, 0.0245
NEWS10 0.287 1000 9.1540, 0.0245 9.002, 0.0185 7.8563, 0.0214 0.8641, 0.0962 0.7452, 0.105 0.6223, 0.115
NEWS35 0.287 285.7 18.5894, 0.2329 17.6520, 0.2032 3.6764, 0.4037 0.4726, 0.0562 0.4528, 0.0864 0.074, 0.0188
NEWS100 0.287 100 48.3878, 0.5620 49.6386, 0.8520 8.1432, 0.0476 1.9850, 0.1824 2.2014, 0.2350 0.507, 0.0171
In Fig. 4, we depict the counterfactual RMSE obtained using Hi-CI as compared to
O-NN, PM, Deep-Treat+, validating our claim of outperforming the state of art approaches
for CI.
Figure 4: Comparison against baselines using counterfactual RMSE metric on Syn10 dataset
for N = 10000.
5.4.2 High cardinality treatments with continuous dosages
In Table 7 we depict the comparative dosage-response values for different datasets averaged
over all treatments and individuals, in terms of
√
MISE. We observe that the Hi-CI
framework outperforms the state of the art DNN-based approach, DRNet by a considerable
margin for several treatment counts.
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Table 7: Comparing with baselines: Hi-CI for continuous treatments, E > 1.
Dataset DRNet Hi-CI
NEWS2 7.7, 0.2 6.2450, 0.1254
NEWS4 11.5, 0.0 11.0842, 0.1358
NEWS8 10.0, 0.0 8.7540, 0.1032
NEWS16 10.2, 0.0 8.6560, 0.0452
6. Discussions and Conclusions
In CI applications, one commonly encounters situations where there are large number of
covariates and large number of treatments in real-world observational studies. The biggest
hindrance in such a scenario is in inferring which of the covariates is the actual confounder
among the large number of covariates. Furthermore, the complexity of the situation is
enhanced since one needs to determine such confounding effects per treatment, for a large
number of treatments.
We tackle these seemingly hard scenarios using a generalized Hi-CI framework. Our ap-
proach is based on a fundamental assumption that the high-dimensional covariates are often
sparse, and can be represented in a low-dimensional space. Naturally, we employed an auto-
encoder to represent covariates in a low-dimensional space, without losing much information
in the original covariates. Alongside, we also incorporate a decorrelating loss function which
ensures that we obtain an equivalent representation of the covariate space with a reduced
confounding bias. Furthermore, using the fact that often several treatments/interventions
are perhaps similar, we used an embedding in order to obtain a low-dimensional represen-
tation of the treatment. In literature, continuous treatments are used, which we addressed
by using per-dosage level embedding.
We performed extensive experimental analysis of Hi-CI for synthetic Syn dataset and
semi-synthetic NEWS dataset. For high cardinality discrete treatments, we observed that
when we increase the number of treatments, not only does Hi-CI perform considerably
well in spite of CI being an ill-posed problem, but also is able to outperform the state of
art DNN approaches. We further show that the proposed framework handles continuous
valued dosages which may or not may be confounded by covariates. We also depicted the
decreasing trend in RMSE across epochs, which leads us to understand that the model has
indeed trained well. Overall, the theory and results demonstrate that Hi-CI can be regarded
as a generalized causal inference framework for tackling high dimension covariates and large
number of treatments which may be continuous or discrete valued in observational studies.
As a future work, we intend to analyse scenarios where P  N , which occur in biological
applications such as gene intervention studies.
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Appendix A.
In this appendix, we provide details of the experiments performed to evaluate Hi-CI frame-
work. Specifically, we describe the dataset preparation, training mechanism and hyperpa-
rameter tuning.
A.1 Implementation
A.1.1 Algorithm
We provide the implementation details of Hi-CI framework in Algorithm 1 and 2. Specif-
ically, in algorithm 1 we explain the methodology used for splitting dataset D into train
(DCI), validation (Dval), test (Dtst) sets. We also explain the mechanism for hyperparam-
eter selection. On the otherhand, algorithm 2 outlines the procedure for training Hi-CI for
the given set of hyperparameters. We initialise the parameters W of Hi-CI using random
normal distribution. We use Adam optimizer with inverse time decay learning rate for gra-
dient descent. In algorithm 1, hparam values specifies the range of hyperparameters for
grid-search as in Table 8, num unique treat(·) returns the number of unique treatments in
the dataset passed as argument, get gs hparams(·) returns set containing exhaustive com-
bination of hyperparameters, get best params(·) returns Hi-CI parameters corresponding
to best validation loss and get metric(·) returns performance metrics of trained Hi-CI
on dataset passed as argument. Similarly in algorithm 2, initialize(·) initializes param-
eters of Hi-CI using random normal distribution, get random batches(·) creates random
batches of the dataset with batch size as specified in the argument, train(·) trains Hi-CI,
check convergence(·) checks for convergence on Dval, get final params(·) returns learned
parameters Wf of Hi-CI and get val loss(·) returns loss L on Dval corresponding to Wf .
Algorithm 1 Hi-CI
1: procedure Hi-CI(D, K, hparam values, E = 1)
2: Split D into DCI ,Dval,Dtst
3: while num unique treat(DCI) < K do
4: Split D into DCI ,Dval,Dtst
5: Lval = ∅,W = ∅
6: gs hparams = get gs hparams(hparam values)
7: for gs hparam in gs hparams do
8: Lval,W ← trainer(gs hparam,DCI ,Dval)
9: W ′ = get best params(Lval,W )
10: PEHE,MAPEATE = get metric(Dtst,W
′)
return PEHE,MAPEATE ,W
′
A.1.2 Parameter Tuning and Model Selection
We select the optimal parameters W ′ for Hi-CI by performing an exhaustive grid-search on
the hyperparameters values mentioned in Table 8.
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Algorithm 2 TrainHi−CI
1: procedure trainer(gs hparam,DCI ,Dval)
2: W = initialize()
3: total epochs = gs hparam.total epochs
4: batch size = gs pharam.batch size
5: while epoch <= total epochs do
6: Dbatches = get random batches(DCI , batch size)
7: for Dbatch in Dbatches do
8: W = train(W,Dbatch, gs hparam)
9: if check convergence(W,Dval) then
10: Wf = get final params(W )
11: break
12: epoch = epoch+ 1
13: L = get val loss(Wf ,Dval)
return L,Wf
Table 8: Hyperparameters for grid-search (hparam values)
Parameter Values
Batch size 64, 128, 256, 512
Total epochs 1000
Learning rate 0.06, 0.08, 0.1, 0.12, 0.14, 0.16
Learning rate decay 0.6, 0.65, 0.7, 0.75
No. of iterations per decay 1, 2
Train set split ratio 0.6
Validation set split ratio 0.2
Test set split ratio 0.2
No. of encoder layers 1, 2, 3, 5, 7
No. of decoder layers 3, 4, 5, 6, 7, 8
No. of outcome layers 3, 4, 5, 6, 7, 8
No. of hidden nodes in encoder layers 100, 150, 200, 250
No. of hidden nodes in decoder layers 100, 175, 250, 325, 400
No. of hidden nodes in outcome network 100, 200, 250, 300, 400, 500
L-2 regularization co-efficient for Φ,Ψ,Ωe 0.01, 0.001, 0.0001
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Table 9: Logistic regression hyperparameters for grid-search
Parameter Values
Inverse of regularization strength 0.001, 0.01, 0.1, 1, 10
Solver newton-cg, sag, saga, lbfgs
Tolerance for stopping criteria 1e-4, 1e-2
A.1.3 Learning θTk :
We use the multi-class logistic regression library of scikit-learn for learning θTk in (9). The
range of hyperparameters for grid-search in logistic regression is given in Table 9.
A.2 Baselines
In order to make fair comparison of Hi-CI with baselines, we used consistent train, vali-
dation and test sets. Additionally, same set of hyperparameters were used for best model
selection across all approaches.
A.3 Compute Infrastructure
All experiments in this paper were run on Nvidia Tesla V100 GPU with 32 GB memory
and Intel Xeon CPUs with 64 GB RAM.
XN×P Encoder Φ
Decoder Ψ
Lae(X,Ψ(Φ(X)))
Ψ(Φ(X))
Φ(X)
Lce(Φ(X))
L2,1(MD(Φ(X)))
p(Tk) tn, 1 ≤ n ≤ N
en, 1 ≤ n ≤ N
LRMSE(yn, yˆn)yn , 1 ≤ n ≤ N
Ω1
Ω2
ΩE
forward propagation
backward propagation
Decorrelation network Outcome prediction network
Figure 5: Detailed architecture (with notations) of Hi-CI is depicted. Dotted red arrows
highlight joint learning of decorrelating and outcome prediction network. X ∈
RN×P , Ψ(Φ(X)) ∈ RN×P , Φ((X)) ∈ RN×L, tn ∈ RK×1, 1 ≤ k ≤ K.
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